Printer Friendly
The Free Library
14,505,950 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

NEOPROBE'S GAMMA DETECTION SYSTEMS GET APPROVAL IN JAPAN.


The Neoprobe(R) 1500 and neo2000(TM) gamma detection systems have received licensing approval from the Japanese Ministry of Health and Welfare The Ministry of Health and Welfare is a branch of the government of South Korea. External links
  • Official website


    
, and Century Medical will begin marketing Neoprobe's products immediately.

Neoprobe Corporation (Nasdaq/NMS:NEOP NEOP Neoprobe Corporation (stock symbol)
NEOP Near Earth Object Program
NEOP New England Order of Protection
NEOP Nuclear Explosive Operating Procedure
), Dublin, Ohio Dublin is a city in Delaware, Franklin, and Union counties in the U.S. state of Ohio. The population was 31,392 at the 2000 census. In 2006, the population was estimated to be 36,565[1], and Dublin continues to be one of the fastest-growing suburbs of Columbus. , has signed an exclusive distribution agreement with Century Medical, Inc., Tokyo, Japan, to market and distribute its gamma detection products.

Matthew Bowman Matthew Bowman (born January 31, 1990 in Barnsley, South Yorkshire) is an English striker and midfielder who currently plays for Sheffield Wednesday. Although an Academy player he was called up to the senior squad at the start of 2006-07 season to ease the club's injury problems. , Neoprobe's Sr. vice president of marketing and operations stated, "In addition to recently obtaining the CE Mark approval in Europe for the neo2000, our partnership with Century Medical, one of the premier medical product distributors in Japan, strengthens Neoprobe's strategy for global market penetration in the rapidly growing gamma guided surgery marketplace."

Century Medical, Inc., is a $110 million division of Tokyo-based, Itochu Corporation (ITOCY), a $123 billion dollar international comprehensive trading firm founded in 1858. Century Medical is specialized in the healthcare field, with sales people operating from six regional offices in Japan. Over the past two decades, Century Medical has expanded its medical product partnerships with U.S. companies. Among its other alliances in the surgical and medical market segments are ATS Medical, Wright Medical Technology, Integra LifeSciences, and Cordis Webster.

Neoprobe's Neoprobe 1500 and neo2000 gamma detection systems are currently approved in the United States, Europe, Japan and other international markets.

Neoprobe Corporation designs, develops, manufactures and markets innovative probes and control units for surgeons' use in gamma guided surgical procedures, including intraoperative lymphatic lymphatic /lym·phat·ic/ (lim-fat´ik)
1. pertaining to lymph or to a lymphatic vessel.

2. a lymphatic vessel.


lym·phat·ic
adj.
 mapping. Neoprobe devices are indicated for external and intraoperative detection of radioactivity in body tissues or organs, such as bowel, bone, lymphatics Lymphatics
Channels that are conduits for lymph.

Mentioned in: Colon Cancer, Rectal Cancer
 and red blood cells Red blood cells
Cells that carry hemoglobin (the molecule that transports oxygen) and help remove wastes from tissues throughout the body.

Mentioned in: Bone Marrow Transplantation

red blood cells 
, where radiopharmaceuticals are administered.

For more information, call 614/793-7500.
COPYRIGHT 1999 Worldwide Videotex
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:NEOPROBE'S GAMMA DETECTION SYSTEMS GET APPROVAL IN JAPAN.
Publication:Biotech Equipment Update
Geographic Code:9JAPA
Date:Apr 1, 1999
Words:273
Previous Article:FDA APPROVES GUIDANT'S MEGALINK STENT FOR BILIARY INDICATIONS.
Next Article:NEONATAL BLOOD ANALYSIS MONITOR DECREASES TRANSFUSIONS.
Topics:



Related Articles
Neoprobe files product marketing application for surgical cancer product with European authorities.
Neoprobe's product marketing application formally accepted for review by European authorities.
Superiority in Cancer Lymphatic Mapping Technology.
Neoprobe's Gamma Detection Systems Receive Approval in Japan and Distribution Agreement Completed.
Neoprobe Announces Positive Third Quarter Results and Provides Business Update.
Neoprobe Announces Japanese Distribution for Quantix Products.
Neoprobe's Lymphoseek Issued Japanese Patent.
Neoprobe Announces Extension of Marketing Agreement with Ethicon Endo-Surgery, Inc.
Neoprobe Introduces Enhanced Gamma Detection System.
Neoprobe Announces Annual Meeting Results.(Financial report)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles